TechFlow news, on August 5, biopharmaceutical company Silo Pharma (Nasdaq: SILO) today announced the launch of a cryptocurrency asset management strategy and appointed Corwin Yu, an expert in crypto infrastructure, as the first member of its cryptocurrency advisory committee. The strategy will focus on major digital assets such as Bitcoin, Ethereum, and SOL.
Add to Favorites
Share to Social Media





